EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 258.7 ILa | -2.74% |
|
-4.15% | -13.71% |
| Apr. 02 | Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd | CI |
| Mar. 20 | Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 17M 6.32B | Sales 2025 * | 31.5M 11.71B | Capitalization | 36.17M 13.45B |
|---|---|---|---|---|---|
| Net income 2024 * | -20M -7.43B | Net income 2025 * | -17M -6.32B | EV / Sales 2024 * | 2.13 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.15 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 142 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on Evogene Ltd.
More press releases
| 1 day | -1.95% | ||
| 1 week | -3.37% | ||
| Current month | +4.24% | ||
| 1 month | -9.03% | ||
| 3 months | -3.16% | ||
| 6 months | +14.14% | ||
| Current year | -13.01% |
1 week
255.00
274.20
1 month
231.20289.10
Current year
231.20370.00
1 year
189.30610.40
3 years
189.301 323.00
5 years
189.303 350.00
10 years
189.306 017.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-12-31 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 22-03-31 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 04-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 21-11-16 |
Sarit Firon
CHM | Chairman | 58 | 16-08-10 |
Leon Recanati
BRD | Director/Board Member | 76 | 05-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-12 | 258.7 | -2.74% | 10 970 |
| 24-05-09 | 266 | -0.45% | 14,842 |
| 24-05-08 | 267.2 | +0.34% | 19,198 |
| 24-05-07 | 266.3 | -0.34% | 23,376 |
| 24-05-06 | 267.2 | -1.00% | 10,211 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 12, 2024 at 07:04 am EDT
More quotes
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Calendar
2024-05-23
- Q1 2024 Earnings Release
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.01% | 36.15M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- EVGN Stock
